School of Medicine


Showing 1-20 of 62 Results

  • Jen Haensel

    Jen Haensel

    Basic Life Res Scientist, Ophthalmology Research/Clinical Trials

    BioI am a Research Scientist in the Roberts Vision Development & Oculomotor Lab at Stanford University’s Department of Ophthalmology, working at the intersection of vision science, neuroscience, and experimental psychology. My current research uses eye-tracking, photorefraction, and psychophysics to study oculomotor development and visual function in amblyopia, strabismus, and concussion. I also work on developing methodology to record accommodative measurements and gaze behaviour in dynamic, naturalistic settings.

    I completed my PhD in Experimental Psychology at Birkbeck, University of London (UK), where I used advanced eye-tracking techniques to study the influence of postnatal experience on social gaze behaviour. Prior to joining Stanford, I also worked as a postdoctoral researcher at the University of Bath (UK), developing empirical human-robot interaction studies to inform the ethical design of humanoid robots.

  • Bereketeab Haileselassie

    Bereketeab Haileselassie

    Assistant Professor of Pediatrics (Critical Care)

    Current Research and Scholarly InterestsMy laboratory is focused on understanding the cellular mechanisms which mediate end-organ failure in pediatric sepsis. Our current work focuses on determining the role of altered mitochondrial dynamics in sepsis-induced multi-organ dysfunction syndrome (MODS). Specifically, we focus on understanding the mechanisms that mediate derangements in mitochondrial fission and autophagy in sepsis.

  • Jens Hainmueller

    Jens Hainmueller

    Kimberly Glenn Professor and Professor of Political Science

    BioJens Hainmueller is the Kimberly Glenn Professor in Political Science and Director of Graduate Studies of the Department of Political Science at Stanford University. He is the Faculty Co-Director of the Stanford Immigration Policy Lab that is focused on the design and evaluation of immigration and integration policies and programs.

    His research interests include statistical methods, causal inference, immigration, and political economy. He has published over 65 articles, many of them in top general science journals (e.g. Science, Nature, PNAS) and top field journals in political science, statistics, economics, and business. His statistical methods are used by organizations to conduct causal inferences in various settings. He has also published multiple open source software packages. His research has received funding from organizations such as Schmidt Futures, the Robin Hood Foundation, the Robert Wood Johnson Foundation, the National Science Foundation, the National Institute of Health, and the National Bureau of Economic Research. His research has won various awards including the Gosnell Prize for Excellence in Political Methodology, the Warren Miller Prize, the Robert H. Durr award, and the Emerging Scholar award by the Society of Political Methodology. He was selected as an Andrew Carnegie Fellow and inducted as a Fellow of the Society of Political Methodology. He has received an honorary degree from the European University Institute (EUI).

    Hainmueller received his PhD from Harvard University and also studied at the London School of Economics, Brown University, and the University of Tübingen. Before joining Stanford, he served on the faculty of the Massachusetts Institute of Technology.

  • Lou Halamek

    Lou Halamek

    Professor of Pediatrics (Neonatology) and, by courtesy, of Obstetrics and Gynecology

    Current Research and Scholarly Interests1. development of hospital operations centers coupled with sophisticated simulation capabilities
    2. re-creation of near misses and adverse events
    3. optimizing human and system performance during resuscitation
    4. optimizing pattern recognition and situational awareness at the bedside
    5. evaluation and optimization of debriefing
    6. patient simulator design

  • Scott S. Hall, Ph.D

    Scott S. Hall, Ph.D

    Professor of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Sciences)

    Current Research and Scholarly InterestsMy primary area of scholarly and clinical interest is the pathogenesis of problem behaviors shown by individuals diagnosed with intellectual and developmental disabilities (IDD), particularly those with neurogenetic forms of IDD, such as fragile X syndrome, Cornelia de Lange syndrome and Prader-Willi syndrome. My work aims to both advance understanding of these disorders and to identify effective new treatment approaches for pediatric and adult patient populations by state-of-the-art methodologies, such as brain imaging, eye tracking and functional analysis to determine how environmental and biological factors affect the development of aberrant behaviors in these syndromes. The end goal of my research is to create patient-specific methods for treating the symptoms of these disorders.

  • Meghan Halley

    Meghan Halley

    Sr Research Scholar, School of Medicine - Biomedical Ethics

    BioMeghan Halley, PhD, MPH, is a Senior Research Scholar in the Center for Biomedical Ethics (SCBE) at Stanford University. She completed her doctorate in medical anthropology from Case Western Reserve University in 2012, and additional training in health services research at the Palo Alto Medical Foundation Research Institute from 2012 through 2016. Her current research focuses at the intersection of the ethics and economics of new genomic technologies. Her current projects include examining ethical issues related to sustainability and governance of patient data and relationships when large clinical genomic studies transition to new models of funding; ethnographic work exploring how diverse stakeholders perceive value in the use of genome sequencing for diagnosis of rare diseases; and the development of new measures for assessing patient-centered outcomes in pediatric rare diseases.

  • Joachim Hallmayer

    Joachim Hallmayer

    Professor of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsPrincipal Investigator
    Infrastructure to facilitate discovery of autism genes
    The purpose of this project is to facilitate the discovery of the genes that contribute autism by maintaining an infrastructure which research groups studying the genetics of autism can work collaboratively. This will be
    accomplished through workshops, a Virtual Private Network, and access to a database that includes phenotype and genotype data from all participating groups.

    Principal Investigator
    A California Population-Based Twin Study of Autism
    This will address several fundamental questions: (1) What is the heritability of autism (2) What is the contribution of genetic factors to variation in symptom dimensions? (3) Is there a continuum between the quantitative neurocognitive traits and clinical disorder? (4) What proportion of the variance in the neurocognitive traits is accounted for by genetic and non-genetic factors?

    Co-Investigator
    Center for Integrating Ethics in Genetics Research(Cho)
    The goal of this project is to serve as a center of excellence in neurogenetics research, to develop a national model for bench, to bedside research ethics consultation, and to provide training opportunity in biomedical ethics.

    Co-Investigator
    Gene, Brain and Behavior in Turner Syndrome(Reiss)
    The primary objective of this project is to use advanced, multi-modal magnetic resonance imaging (MRI) techniques, analyses of X chromosome parent-of-origin and cognitive-behavioral assessment to elucidate the effects of monosomy and X-linked imprinting on neurodevelopment and neural function in a large cohort of young girls with Turner syndrome, pre-estrogen replacement.

    Project Director
    Project F: Genomic Analysis in narcolepsy cataplexy
    The goal of the project is to locate genes outside the HLA region that influence susceptibility to narcolepsy. In order to localize these genes we will carry out a linkage and association study in the most extensive world-wide collection of DNAs from well-characterized patients with narcolepsy and their families.

  • Bonnie Halpern-Felsher

    Bonnie Halpern-Felsher

    Marron and Mary Elizabeth Kendrick Professor of Pediatrics and Professor, by courtesy, of Epidemiology and Population Health and of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsResearch focuses on developmental, cognitive and psychosocial factors involved in adolescents’ and young adults’ health-related decision-making, perceptions of risk and vulnerability, health communication and risk behavior. My research has focused on understanding and reducing health risk behaviors such as tobacco use, alcohol and marijuana use, risky driving, and risky sexual behavior.

  • Frank Hanley

    Frank Hanley

    Lawrence Crowley, M.D., Endowed Professor of Child Health

    Current Research and Scholarly InterestsHis research and clinical work focuses on the development of interventional techniques for fetal and neonatal treatment of congenital heart disease, pulmonary, vascular physiology, and the neurologic impact of open-heart surgery. He developed and pioneered the “unifocalization” procedure, in which a single procedure is used to repair a complex and life-threatening congenital heart defect rather than several staged open-heart surgeries as performed by other surgeons.

  • Maha Hanna

    Maha Hanna

    Clinical Assistant Professor, Pediatrics

    Current Research and Scholarly InterestsA bad latch means maternal excruciating pain, ineffective milk transfer with subsequent weight loss, hypoglycemia, higher risk of hyperbilirubinemia and dehydration fever.All of the above led to early cessation of breastfeeding; 46% of mothers who initiate exclusive breastfeeding stop within the first 12 weeks because of difficult latch. I developed a latch tutorial focusing on step-by step-in striations for achieving an effective, non-painful latch.

  • Antonio Hardan, M.D.

    Antonio Hardan, M.D.

    Professor of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsThe neurobiology of autism
    Neuroimaging in individuals with autism
    Psychopharmacological treatment of children and adults with autism and/or developmental disorders
    The neurobiology and innovative interventions of several neurogenic disorders including DiGeorge Syndrome (Velocardiofacial syndrome; 22q11.2 mutations), PTEN mutations, and Phelan McDermid Syndrome (22q13 mutations).

  • Keren Haroush

    Keren Haroush

    Assistant Professor of Neurobiology

    Current Research and Scholarly InterestsOur laboratory studies the mechanisms by which highly complex behaviors are mediated at the neuronal level, mainly focusing on the example of dynamic social interactions and the neural circuits that drive them. From dyadic interactions to group dynamics and collective decision making, the lab seeks a mechanistic understanding for the fundamental building blocks of societies, such as cooperation, empathy, fairness and reciprocity.

  • Phillip M. Harter, M.D.

    Phillip M. Harter, M.D.

    Associate Professor (Teaching) of Emergency Medicine, Emeritus

    Current Research and Scholarly InterestsMedical Education, particularly the role of simulation (part-task trainers, human patient simulators and virtual reality) in the education of medical students and residents. Also, the use of the internet for distance learning in health care professions.

  • Trevor Hastie

    Trevor Hastie

    John A. Overdeck Professor, Professor of Statistics and of Biomedical Data Sciences
    On Partial Leave from 01/01/2024 To 03/31/2024

    Current Research and Scholarly InterestsFlexible statistical modeling for prediction and representation of data arising in biology, medicine, science or industry. Statistical and machine learning tools have gained importance over the years. Part of Hastie's work has been to bridge the gap between traditional statistical methodology and the achievements made in machine learning.

  • Melanie Hayden Gephart

    Melanie Hayden Gephart

    Professor of Neurosurgery and, by courtesy, of Neurology

    BioI am a brain tumor neurosurgeon, treating patients with primary and metastatic brain tumors. I treat patients with malignant and benign tumors, including glioma, brain metastases, meningioma, and vestibular schwannomas. I direct the Stanford Brain Tumor Center and the Stanford Brain Metastasis Consortium, collaborative unions of physicians and scientists looking to improve our understanding and treatment of brain tumors. My laboratory seeks greater understanding of the mechanisms driving tumorigenesis and disease progression in malignant brain tumors. We study how rare cancer cell populations survive and migrate in the brain, inadvertently supported by native brain cells. We develop novel cell free nucleic acid biomarkers to track brain cancer treatment response, relapse, and neurotoxicity. Our bedside-to-bench-to-bedside research model builds on a foundation of generously donated patient samples, where we test mechanisms of brain cancer growth, develop novel pre-clinical models that reliably recapitulate the human disease, and facilitate clinical trials of new treatments for patients with brain cancer.

    www.GephartLab.com
    www.GBMseq.org
    https://stan.md/BrainMets
    @HaydenGephartMD

  • John P. Hegarty II

    John P. Hegarty II

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioI am a neuroscientist and Principal Investigator of the Stanford Clinical Neuroscience (CNS) Lab in the Department of Psychiatry and Behavioral Sciences as well as Director of Neuroimaging for the Autism and Developmental Disorders Research Program at Stanford. My innovative research studies clinical aspects of cognitive and behavioral neuroscience, with a special focus on examining the neural circuitry associated with important brain-behavior relationships that may underlie different psychological and psychiatric domains in autistic children, adolescents, and adults. The ultimate goal of this research is to improve our understanding of the development of different cognitive and behavioral skills in order to develop mechanistically driven interventions that will improve precision medicine for mental health. Biologically based diagnosis and treatment are extremely limited for most psychological and psychiatric conditions but also critically needed to increase early identification and improve treatment outcomes, especially for neurodevelopmental disorders in which early intervention is the most beneficial. My early career research has primarily focused on clinical neuroscience using neuroimaging (e.g., MRI & EEG) to examine the effects of different drugs and behavioral interventions on the brain, especially for developing biomarkers for improving treatment planning and monitoring biological changes in response to single dose and clinical trials.

    My primary contributions to science thus far fall within these major categories: 1) identifying the neural correlates of individual differences in cognition and behavior, 2) developing new interventions and investigating the neurobiological substrates of response to treatment, 3) examining different factors that contribute to brain development, 4) summarizing and increasing accessibility to autism-related research, and 5) methods development for neuroimaging studies. My earliest research investigated the neurobiology of alexithymia, dyslexia, and stress using structural and functional magnetic resonance imaging to test theories of the mechanisms that contribute to differences in cognition and behavior. My subsequent dissertation research, in which I began to focus on neurodevelopmental disorders, examined the neural correlates of response to beta-blockers in autistic adults and also assessed the contribution of cerebellar circuits to the autism phenotype. During my postdoctoral training, I have developed further skills for working with children in multiple clinical research settings, especially for using advanced neuroimaging approaches to examine important brain-behavior relationships. This includes a recent K99/R00 from the National Institute of Child Health and Human Development (NCT04278898 & NCT05664789) that will assess the neurobiology of restricted and repetitive behaviors in autistic children and examine the efficacy and target engagement of a novel nutritional supplement and investigational drug, N-acetylcysteine (NAC), in the brain. You can find more information about our NAC studies at https://redcap.link/NACandAutism.